Vir Biotechnology, Inc.

VIR Net selling

CIK 0001706431 #2232 in the set updated 18 Sep 2026

Bought (120 mo)

$139.25M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$251.90M

$24.62M on a plan · $33.77M straight out of an exercise

Sold at will

$193.51M

217 of 429 sales

Net

−$112.66M

−$54.26M against sales at will

By person

36 insiders · 460 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

SVF Endurance (Cayman) Ltd entity

10% owner

$19.00M (1)

$187.45M (143)

−$168.45M

36,345,590

21.48%

$343.47M

+60.7%

Alaska Permanent Fund Corp entity

10% owner

$30.00M (1)

—

+$30.00M

16,666,668

9.85%

$157.50M

+50.0%

Abu Dhabi Investment Authority

Former 10% Owner

$20.00M (1)

—

+$20.00M

3,666,666

2.17%

$34.65M

—

ARCH Venture Partners IX, LLC entity

10% owner

$20.00M (1)

—

+$20.00M

12,321,218

7.28%

$116.44M

—

Burow Kristina

Director

$20.00M (1)

—

+$20.00M

1,000,000

0.5910%

$9.45M

—

NELSEN ROBERT

Director

$20.00M (1)

—

+$20.00M

12,847,529

7.59%

$121.41M

—

SATO VICKI L

Director

—

$13.98M (53)

−$13.98M

1,078,391

0.6373%

$10.19M

−35.4%

Virgin Herbert

EVP, Research & CSO

—

$11.69M (62) scheduled

−$11.69M

262,500

0.1551%

$2.48M

—

Pang Phillip

EVP & Chief Medical Officer

—

$11.02M (64) scheduled

−$11.02M

250,111

0.1478%

$2.36M

+3,116%

Parrish Jay

Chief Business Officer

—

$10.69M (12) scheduled

−$10.69M

9,260

0.0055%

$87.51K

0.0%

Temasek Holdings (Private) Ltd entity

10% owner

$10.00M (1)

—

+$10.00M

5,499,999

3.25%

$51.97M

—

Horn Howard

CFO

—

$4.73M (12)

−$4.73M

230,712

0.1363%

$2.18M

−16.9%

MORE ROBERT J

Director

—

$3.44M (12)

−$3.44M

1,044,684

0.6174%

$9.87M

—

SCANGOS GEORGE A

Director

—

$3.09M (14)

−$3.09M

3,757,298

2.22%

$35.51M

−32.5%

De Backer Marianne

President and CEO

—

$2.26M (6) scheduled

−$2.26M

1,001,263

0.5917%

$9.46M

—

Rice Steven J.

Chief Administrative Officer

—

$1.22M (7) scheduled

−$1.22M

106,840

0.0631%

$1.01M

+5,091%

Ramasastry Saira

Director

—

$761.09K (5) scheduled

−$761.09K

22,619

0.0134%

$213.75K

—

HANLY ANN M.

EVP & Chief Technology Officer

$499.85 (1)

$473.24K (6) scheduled

−$472.74K

117,913

0.0697%

$1.11M

+10,316%

de Verneuil Vanina

EVP, General Counsel, Corp Sec

—

$411.09K (11) scheduled

−$411.09K

112,982

0.0668%

$1.07M

+64.4%

Napolitano Janet

Director

—

$281.19K (5) scheduled

−$281.19K

21,216

0.0125%

$200.49K

—

Sigal Charles Elliott

Director

$246.34K (4)

—

+$246.34K

49,806

0.0294%

$470.67K

—

Sabatini Brent

SVP, Chief Accounting Officer

—

$142.14K (7) scheduled

−$142.14K

61,902

0.0366%

$584.97K

+88.1%

Eisner Mark

EVP and Chief Medical Officer

—

$106.31K (5) scheduled

−$106.31K

154,024

0.0910%

$1.46M

—

O'Byrne Jason

EVP & Chief Financial Officer

—

$68.93K (3) scheduled

−$68.93K

162,615

0.0961%

$1.54M

+5,084%

Lee Sung

EVP & Chief Financial Officer

—

$59.40K (1)

−$59.40K

100,492

0.0594%

$949.65K

—

Friedl-Naderer Johanna

EVP & Chief Operating Officer

—

$33.82K (1)

−$33.82K

148,518

0.0878%

$1.40M

—

Bill & Melinda Gates Foundation entity

10% owner

—

—

—

2,777,777

1.64%

$26.25M

—

Q-Ventures Program II (Co-Invest Holdings) Ltd. entity

Former 10% Holder

—

—

—

1,666,666

0.9849%

$15.75M

—

Frueh Klaus

Director

—

—

—

440,621

0.2604%

$4.16M

+98.3%

SHARP PHILLIP A

Director

—

—

—

165,618

0.0979%

$1.57M

—

Hatfield Jeffrey S.

Director

—

—

—

39,806

0.0235%

$376.17K

—

Farid Ramy

Director

—

—

—

32,000

0.0189%

$302.40K

—

BISCHOFBERGER NORBERT W

Director

—

—

—

32,000

0.0189%

$302.40K

—

Coughlin Timothy

Director

—

—

—

16,000

0.0095%

$151.20K

—

PEREZ ROBERT J

Director

—

—

—

15,806

0.0093%

$149.37K

—

Nishar Dipchand

Director

—

—

—

3,374

0.0020%

$31.88K

—

Individual transactions

5

Insider

Date

Role

Action

Shares

Price

Amount

Pang Phillip

2 Jan 2024

EVP & Chief Medical Officer

Exercised, kept

47,591

$1.53

$72.81K

Pang Phillip

2 Jan 2024

EVP & Chief Medical Officer

Exercised, kept

13,576

$1.58

$21.38K

Pang Phillip

2 Jan 2024

EVP & Chief Medical Officer

Exercised, kept

18,833

$0.86

$16.10K

Virgin Herbert

9 Aug 2022

EVP, Research & CSO

Exercised, kept

7,916

$10.40

$82.29K

Virgin Herbert

9 Aug 2022

EVP, Research & CSO

Exercised, kept

70,177

$1.53

$107.37K

Showing 250 of 460 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 433

Amendments (4/A) skipped 11

Filings about a different issuer 0

Unreadable filings 0

Joint filings 76

Sales on a Rule 10b5-1 plan 82

Sales straight out of an exercise 130

Sales at will 217

Transactions with no price 0

Shares from compensation/vesting 178,530,840

Sales filed before the plan box existed 178

History held since 10 Oct 2019